Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 22381 - 22400 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FB01) inotuzumab ozogamicin | Besponsa 1 mg powder for injection, 1 vial | Powder for I.V. infusion 1 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerAustraliaPtyLtd |
| Australia | (L01FB01) inotuzumab ozogamicin | Besponsa 1 mg powder for injection, 1 vial | Powder for I.V. infusion 1 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerAustraliaPtyLtd |
| Australia | (L01FB01) inotuzumab ozogamicin | Besponsa 1 mg powder for injection, 1 vial | Powder for I.V. infusion 1 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerAustraliaPtyLtd |
| Australia | (L01FB01) inotuzumab ozogamicin | Besponsa 1 mg powder for injection, 1 vial | Powder for I.V. infusion 1 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerAustraliaPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex 100 mg/5 mL injection, 5 mL vial | Solution concentrate for I.V. infusion 100 mg in 5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex 100 mg/5 mL injection, 5 mL vial | Solution concentrate for I.V. infusion 100 mg in 5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
Pages
